Tylosin

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin sodium (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton)

Feed continuously as sole ration for the last 28 to 42 days on ration. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin sodium (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration for the last 28 to 42 days on ration. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) plus monensin sodium (10 to 40 g/ton) in combination with tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration for the last 28 to 42 days on ration. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal. 

Liquid Type B Medicated Feeds must bear the following caution: 

Inadequate mixing (recirculation or agitation) of monensin liquid Type B medicated feed has resulted in increased monensin concentration, which has been fatal to cattle. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine is fed at concentrations of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed (based on 90% dry matter basis) to provide 90 to 430 mg ractopamine/head/day in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day. Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day in heifers being fed for slaughter.

Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to E. bovis and E. zuernii and reduction in incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin in combination with 8 to 10 g/ton tylosin phosphate.

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g monensin USP per ton of complete feed to provide 0.14 to 0.42 mg monensin/lb of body weight/day, depending on severity of coccidiosis challenge, up to a maximum of 480 mg monensin/head/day.

Tylosin is added to the cattle diets at concentrations of 8 to 10 g tylosin phosphate per ton complete feed to provide 60 to 90 mg tylosin/head/day.

Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day in heifers fed in confinement for slaughter. Feed melengestrol acetate in this combination for the final 28 to 42 days.

Feed continuously as sole ration during the last 28 to 42 days on feed. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Do not use in calves to be processed for veal. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in cattle fed in confinement for slaughter.

13.6 to 27.2 grams decoquinate per ton and 5 to 30 grams monensin per ton and 8 to 10 grams tylosin per ton.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.Feed only to cattle fed in confinement for slaughter. Feed continuously as the sole ration to provide 22.7 mg of decoquinate per 100 lb body weight per day, 50 to 360 mg of monensin per head per day, and 60 to 90 mg of tylosin per head per day. Feed at least 28 days during period of exposure to coccidiosis or when it is likely to be a hazard. Bentonite should not be used in decoquinate feeds. Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. 

Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Melengestrol acetate (0.125 to 1. 0 mg/lb is top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton), and zilpaterol (6.8 g/ton).

Feed continuously as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. 

Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed. 

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. 

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.” 2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole rotation containing 9.8 to 24.6 grams/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; combined with monensin 10 to 40 grams per ton to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day; tylosin 8 to 10 grams per ton to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 milligrams per head per day for the last 28 to 42 days on feed.

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. 

Ractopamine HCl is not for animals intended for breeding. 

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds storedin recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tankto the top. Recirculate daily, as directed in this paragraph evenwhen the Type C feed is not used." For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems:“Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin per ton of complete feed at a rate of 0.14 mg to 0.42 mg monensin per pound of body weight depending on the severity of coccidiosis challenge up to 480 mg per head per day.

Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin per head per day.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration. A withdrawal time has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat),prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii,reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. 

Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.

Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.

Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration to provide 70 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate.

Feed a minimum of 1.0 lb/hd/day continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day (depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg/hd/day tylosin. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).

Feed continuously as sole ration to provide 90 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and for suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 28 to 42 days on feed.

Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Ractopamine HCl is not for animals intended for breeding.

Special considerations:

Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

For improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle being fed in confinement for slaughter.

Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg monensin/head/day.Monensin is added to feedlot cattle diets at concentrations of 5 to 40 g of monensin USP per ton of complete feed for improved feed efficiency to provide 50 to 480 mg monensin/head/day.Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Component Feed: 6.8 to 24 g/ton zilpaterol to provide 60 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin; mixed or top dressed with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate/head/day.

Feed continuously to cattle during the last 20 to 40 dayson feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Special considerations:1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes, and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Complete feed: 6.8 g/ton zilpaterol to provide 60 to 90 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin; mixed or top dressed with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate/head/day.

Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine.Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

Zilpaterol hydrochloride is fed at a concentration of 6.8 g of zilpaterol hydrochloride per ton of complete feed to provide 60 to 90 mg zilpaterol/head/day in cattle fed in confinement for slaughter during the last 20 to 40 days on feed.

Monensin USP is added to diets for cattle fed in confinement for slaughter at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. 

Tylosin phosphate is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.

Do not use in calves to be processed for veal. Feed continuously as the sole ration during the last 20 to 40 days on feed. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations:

1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.

2) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 3.8 to 7.5. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes and suppression of estrus (heat) in heifers fed in confinement for slaughter for the last 20 to 40 days on feed.

Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. 

Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. 

Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”

2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.

For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers fed in confinement for slaughter.

Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at the rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 100 to 1440 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day. Melengestrol acetate and lasalocid may be fed continuously throughout the time the heifers are being grown and finished for slaughter.

May be fed to heifers in combination with a complete feed containing 8 to 10 g of tylosin per ton for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.

When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. Melengestrol acetate is only for use in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive lasalocid concentrations could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at the rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head lasalocid per day and 100 to 1440 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day and 90 to 360 g/ton tylosin to provide 90 mg tylosin per head per day. Melengestrol acetate, lasalocid, and tylosin may be fed continuously throughout the time the heifers are being grown and finished for slaughter.

When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. For use only in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.

For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef steers and heifers fed in confinement for slaughter.

Feed as the sole ration to provide 22.7 mg of decoquinate per 100 lb. of body weight per day, 50 to 360 mg of monensin per head per day, and 60 to 90 mg tylosin (as tylosin phosphate). Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.

For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.

As tylosin phosphate. Each animal must receive not more than 90 mg/head/day and not less than 60 mg/head/day. Feed continuously as sole ration.

Feed 100 g of tylosin per ton (2.5 pounds Tylan 40 per ton) of complete feed. Feed as the sole ration.

For reduction in severity of effects of atrophic rhinitis.

For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.

Feed 100 g of tylosin per ton (2.5 pounds Tylan 40 per ton) of complete feed for 21 days. Alternatively, feed 100 g of tylosin per ton (2.5 pounds Tylan 40 per ton) of complete feed for at least three weeks, followed by 40 g tylosin per ton of complete feed until pigs reach market weight. Alternatively, feed 40 to 100 grams of tylosin (1.0 to 2.5 pounds of Tylan 40) per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin (as Tylan Soluble) per gallon in drinking water for 3 to 10 days. Feed as the sole ration when feeding Tylan.

For control of swine dysentery associated with Brachyspira hyodysenteriae.

Feed 100 g of tylosin per ton (2.5 pounds Tylan 40 per ton) of complete feed for at least three weeks. Follow with 40 g tylosin per ton (1 pound Tylan 40 per ton) of complete feed until pigs reach market weight.

For the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with Tylan Soluble (tylosin) drinking water.

For the treatment and control of swine dysentery. Feed 40 to 100 grams of tylosin (1.0 to 2.5 pounds of Tylan 40) per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin (as Tylan Soluble) per gallon in drinking water for 3 to 10 days.

For reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of Bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; and control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes).

Withdraw 15 days before swine are slaughtered.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day; 1.25 to 4.54 g/ton of lubabegron (as Experior™) to provide 13 to 90 mg lubabegron per head per day; 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day; and 8 to 10 g/ton of tylosin (as Tylovet®) to provide 60 to 90 mg tylosin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb per head per day) must be trop dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin and tylosin. Feed as the sole ration during the last 14 to 91 days on feed.

Treatment of bovine respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Actinomyces pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium necrophorum and metritis caused by Actinomyces pyogenes.

Treatment should be continued 24 hours after symptoms of the disease have stopped, not to exceed 5 days. Continue treatment 24 hours after symptoms disappear. Do not inject more than 10 milliliters per site. Do not use in lactating dairy cattle. Use a 50-milligram-per-milliliter solution for calves weighing less than 200 pounds. Do not administer within 21 days of slaughter. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Treatment of swine arthritis caused by Mycoplasma hyosynoviae; swine pneumonia caused by Pasteurella species; swine erysipelas caused by Erysipelothrix rhusiopathiae; acute swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae when followed by appropriate medication in the drinking water and/or feed.

Treatment should be continued 24 hours after symptoms of the disease have stopped, not to exceed 3 days. Continue treatment 24 hours after symptoms disappear. Do not inject more than 5 milliliters per site. Do not administer within 14 days of slaughter. If tylosin medicated drinking water is used as followup treatment for swine dysentery, the animal should thereafter receive feed containing 40 to 100 grams of tylosin per ton for 2 weeks to assure depletion of tissue residues.

For increased rate of weight gain, improved feed efficiency, suppression of estrus heat), for reduction of ammonia gas emissions per pound of live weight and hot carcass weight, and for the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in growing beef heifers fed in confinement for slaughter during the last to 91 days on feed.

0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day, 1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg lubabegron per head per day, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day, and 8 to 10 g/ton of tylosin (as tylosin phosphate) (as Tylan™) to provide 60 to 90 mg tylosin per head per day.

The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin and tylosin. Feed as the sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.

4.5 to 9 g ractopamine hydrochloride and 40 or 100 g tylosin phosphate per ton of Type C medicated feed.

Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Include 100 g/ton of tylosin for at least 3 weeks, followed by 40 g/ton until market weight. No increased benefit has been shown when ractopamine concentrations in the diet are greater than 4.5 g/ton. Ractopamine may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.

4.5 to 9 g ractopamine hydrochloride and 40 to 100 g tylosin phosphate per ton of Type C medicated feed.

Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 40 to 100 grams of tylosin per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin tartrate (Tylan™ Soluble) per gallon in drinking water for 3 to 10 days. No increased benefit has been shown when ractopamine concentrations in the diet are greater than 4.5 g/ton. Ractopamine may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter, and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.

Ractopamine hydrochloride (4.5 to 9.0 g/ton) in combination with tylosin phosphate (40 or 100 g/ton). Feed 100 g/ton continuously as sole ration for at least 3 weeks followed by 40 g/ton until market weight.

Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Include 100 g/ton of tylosin for 21 days. No increased benefit has been shown when ractopamine concentrations in the diet are greater than 4.5 g/ton. Ractopamine may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.

Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Include 100 g/ton of tylosin for 21 days. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.

Ractopamine hydrochloride (4.5 to 9.0 g/ton) in combination with tylosin phosphate (40 or 100 g/ton).

Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 40 to 100 grams of tylosin per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin tartrate per gallon in drinking water for 3 to 10 days. Not for animals intended for breeding. Ractopamine may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

4.5 to 9 g Ractopamine hydrochloride and 40 to 100 g tylosin phosphate per ton of Type C medicated feed. 

Feed continuously as the sole ration to finishing swine weighing not less than 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 40 to 100 grams of tylosin per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin tartrate per gallon in drinking water for 3 to 10 days. No increased benefit has been shown when ractopamine concentrations in the diet are greater than 4.5 g/ton. Ractopamine may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicatedfeed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).

Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day. Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Inadequate mixing (recirculation or agitation) of monensin liquid Type C medicated feed has resulted in increased monensin concentration, which has been fatal to cattle. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.

Each pound contains 0.125 to 1.0 mg melengestrol acetate and 45 to 180 mg of tylosin. Feed to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg melengestrol acetate and 60 to 90 mg tylosin per head per day. Prior to feeding, this Type C product must be top-dressed onto a complete feed or mixed into the amount of complete feed consumed by an animal per day.

Feed continuously as sole ration. MGA is for use only in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. When mixing and handling tylosin, use protective clothing, impervious gloves and a dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, ofmonensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™

Feed continuously as sole ration during the last 14 to 91 days on feed.

For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed.

1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™.

Feed continuously as sole ration during the last 14 to 91 days on feed.

For increased rate of weight gain in beef calves 45 days of age and older and weighing up to 400 lbs. This implant is not approved for repeated implantation (reimplantation) with this or any other cattle ear implant as safety and effectiveness has not been evaluated.

Administer one implant containing 100 mg progesterone, 10 mg estradiol benzoate, and 29 mg tylosin tartrate (5 pellets) to each calf by subcutaneous implantation in the middle-third of the ear

For increased rate of weight gain. Not approved for repeated implantation (reimplantation) with this or any other cattle ear implant in growing beef steers and heifers on pasture (stocker, feeder, and slaughter). Safety and effectiveness following reimplantation have not been evaluated.

Administer one implant containing 40 mg trenbolone acetate and 8 mg estradiol (2 pellets) to each steer or heifer by subcutaneous implantation in the middle-third of the ear.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis in finishing swine weighing at least 150 lbs and fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter. No increased benefit has been shown when ractopamine hydrochloride concentrations in the diet are greater than 4.5 g/ton (5 ppm).

Ractopamine hydrochloride 4.5 to 9 g/ton and tylosin phosphate 100 g/ton per ton of Type C medicated feed.

Feed continuously as the sole ration to finishing swine weighing at least 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Include 100 g/ton of tylosin for 21 days. Ractopamine hydrochloride may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae, and control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis in finishing swine weighing at least 150 lbs and fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter. No increased benefit has been shown when ractopamine hydrochloride concentrations in the diet are greater than 4.5 g/ton (5 ppm).

Ractopamine hydrochloride 4.5 to 9.0 g/ton and tylosin phosphate 40 to 100 g/ton per ton of Type C medicated feed.

Feed continuously as the sole ration to finishing swine weighing at least 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Feed 40 to 100 grams of tylosin per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin tartrate (Tylovet®, Soluble) per gallon in drinking water for 3 to 10 days. Ractopamine hydrochloride may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain, improved feed efficiency, increased carcass leanness, control of swine dysentery associated with Brachyspira hyodysenteriae, and control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis in finishing swine weighing at least 150 lbs and fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter. No increased benefit has been shown when ractopamine hydrochloride concentrations in the diet are greater than 4.5 g/ton (5 ppm).

Ractopamine hydrochloride 4.5 to 9 g/ton and tylosin phosphate 100 g/ton per ton of Type C medicated feed.

Feed continuously as the sole ration to finishing swine weighing at least 150 lbs for the last 45 to 90 lbs (group average) of weight gain prior to slaughter. Include 100 g/ton of tylosin for at least 3 weeks, followed by 40 g/ton until market weight. Ractopamine hydrochloride may increase the number of injured and/or fatigued pigs during marketing. Not for animals intended for breeding. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.

For increased rate of weight gain and improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter. Not approved for repeated implantation (reimplantation) with this or any other cattle ear implant in growing beef steers and heifers fed in confinement for slaughter. Safety and effectiveness following reimplantation have not been evaluated.

Administer one implant containing 200 mg trenbolone acetate, 20 mg estradiol, and 29 mg tylosin tartrate (11 pellets) to each steer or heifer by subcutaneous implantation in the middle-third of the ear.

As an aid in the treatment of chronic respiratory disease (CRD) associated with Mycoplasma gallisepticum sensitive to tylosin in broiler and replacement chickens. For the control of CRD associated with Mycoplasma gallisepticum sensitive to tylosin at the time of vaccination or other stress in chickens. For the control of CRD associated with Mycoplasma synoviae sensitive to tylosin in broiler chickens.

2 grams per gallon; should be treated for three days; however, treatment may be administered for one to five days depending on the severity of infection. Treated chickens should consume enough medicated drinking water to provide 50 milligrams (mg) tylosin per pound body weight per day.

Only medicated water should be available to birds. Chickens must not be slaughtered for food within 24 hours after treatment. Do not use in layers producing eggs for human consumption.

For the control of mortality caused by necrotic enteritis (NE) associated with Clostridium perfringens in broiler chickens.

851 to 1,419 mg/gallon (225 to 375 ppm) in drinking water for five consecutive days.

2 grams per gallon; should be treated for three days; however, treatment may be administered for 2 to 5 days depending on the severity of infection. Treated turkeys should consume enough medicated drinking water to provide 60 mg tylosin base per pound body weight per day. Only medicated water should be available to birds.

Only medicated water should be available to birds. Turkeys must not be slaughtered for food within 5 days after treatment. Do not use in layers producing eggs for human consumption.

For the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae. For the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae when followed immediately by tylosin phosphate Type A medicated article in feed. For the control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis when followed immediately by tylosin phosphate Type A medicated article in feed.

For the treatment and control of swine dysentery medicate with 250 mg tylosin per gallon in drinking water for 3 to 10 days, depending upon severity of infection. Alternatively, medicate with 250 mg tylosin per gallon in drinking water for 3 to 10 days, followed by 40 to 100 g of tylosin per ton of complete feed (Type C medicated feed manufactured from tylosin phosphate Type A medicated article) for 2 to 6 weeks. For control of porcine proliferative enteropathies (PPE, ileitis) medicate with 250 mg tylosin per gallon in drinking water for 3 to 10 days, followed by 40 to 100 g of tylosin per ton of complete feed (Type C medicated feed manufactured from tylosin phosphate Type A medicated article) for 2 to 6 weeks. Swine must consume enough medicated water to provide a therapeutic dose.

Only medicated water (250 mg tylosin per gallon) should be available while medicating with BiloVet. Swine must not be slaughtered for food within 48 hours after treatment.

The drug should be fed early in the spring or fall and consumed by the bees before the main honey flow begins, to avoid contamination of production honey. Complete treatments at least 4 weeks prior to main honey flow.

For control of mortality caused by necrotic enteritis (NE) associated with Clostridium perfringens in broiler chickens.

851 to 1,419 mg/gallon (225 to 375 ppm) in drinking water. Administer medicated drinking water for a single five day period in broiler chickens. To assure all birds receive the intended medication, only medicated water should be available.

As an aid in the treatment of chronic respiratory disease (CRD) associated with Mycoplasma gallisepticum in broiler and replacement chickens. For the control of CRD associated with Mycoplasma gallisepticum at the time of vaccination or other stress in chickens. For the control of CRD associated with Mycoplasma synoviae in broiler chickens.

2,000 mg/gallon (528 ppm) in drinking water. Administer medicated drinking water for three days; however, medicated water may be administered for one to five days depending upon severity of infection. Treated chickens must consume enough medicated water to provide 50 mg per pound of body weight per day. Only medicated water should be available to the birds.

For the reduction in severity of effects of infectious sinusitis associated with Mycoplasma gallisepticum.

200 mg/gallon (528 ppm) in drinking water.

For the treatment and control of swine dysentery (SD) associated with Brachyspira hyodysenteriae. For the treatment and control of SD associated with Brachyspira hyodysenteriae when followed immediately by Tylovet Type A medicated article in feed. For the control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis when followed immediately by Tylovet Type A medicated article in feed.

250 mg/gallon (66 ppm) in drinking water. 

Swine dysentery: Administer medicated drinking water for 3 to 10 days, depending upon severity of infection. Alternatively, administer medicated drinking water for 3 to 10 days, followed by 40 to 100 g tylosin per ton of complete feed (Type C medicated feed manufactured from Tylovet Type A medicated article) for 2 to 6 weeks. Only medicated water should be available to swine while medicating with Tylovet Soluble.

Porcine proliferative enteropathies: Administer medicated drinking water for 3 to 10 days, followed by 40 to 100 g of tylosin per ton of complete feed (Type C medicated feed manufactured from Tylovet A medicated article) for 2 to 6 weeks. Only medicated water should be available to swine while medicating with Tylovet Soluble.

For the control of American Foulbrood (Paenibacillus larvae).

200 mg/colony in confectioners/powdered sugar. Administer three treatments of medicated confectioners sugar once weekly for 3 weeks. The 200 mg dose is applied (dusted) over the top bars of the brood chamber.

For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterioum pyogenes.

8 to 10 g/ton of tylosin (0.08 to 0.10 lbs of Tylovet 100) to be fed so that each animal receives not more than 90 mg per head per day and not less than 60 mg per head per day. Feed continuously as the sole ration.

For reduction in severity of effects of atrophic rhinitis.

Feed 100 g of tylosin per ton (1.0 pound Tylovet 100 per ton) of complete feed. Feed continuously as the sole ration.

For control of swine dysentery.

Feed 100 g of tylosin per ton (1.0 pound Tylovet 100 per ton) of complete feed for at least three weeks. Follow with 40 g tylosin per ton (0.4 pound Tylovet 100 per ton) of complete feed until pigs reach market weight.

For the treatment and control of swine dysentery.

Feed 40 to 100 g of tylosin (0.4 to 1.0 pounds of Tylovet 100) per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin (as Tylovet Soluble) per gallon in drinking water for 3 to 10 days.

For control of porcine proliferative enteropathies (PPE, ileitis).

Feed 100 g of tylosin per ton (1.0 pound Tylovet 100 per ton) of complete feed for 21 days. Alternatively, feed 100 g of tylosin per ton (1.0 pound Tylovet 100 per ton) of complete feed for at least three weeks, followed by 40 g tylosin per ton of complete feed until pigs reach market weight. Alternatively, feed 40 to 100 grams of tylosin (0.4 to 1.0 pounds of Tylovet 100) per ton of complete feed for 2 to 6 weeks immediately after medicating with 250 mg tylosin (as Tylovet Soluble) per gallon in drinking water for 3 to 10 days. Feed continuously as the sole ration when feeding Tylovet.

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration to provide 50 to 480 monensin mg/hd/day and 60 to 90 tylosin mg/hd/day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

5 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylan™. Feed continuously as sole ration to provide 50 to 480 mg/hd/day monensin and 60 to 90 mg/hd/day tylosin. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

10 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylan™. Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.

For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

5 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 50 to 480 mg/hd/day monensin and 60 to 90 mg/hd/day tylosin. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).

For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter.

10 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin. 

For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).

0.25 to 2 g/ton fed at a rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg/head/day of melengestrol acetate (as CycleGuard®). Feed continuously as sole ration.

For improved feed efficiency and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration.

For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes.

8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin (as Tylovet®). Feed continuously as sole ration.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness.

9.8 to 24.6 g/ton to provide 90 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For improved feed efficiency and for the prevention and control of coccidiosis due to Eimeria bovis and E. zuernii.

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).

0.125 to 1.0 mg/lb fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg/head/day of melengestrol acetate (as CycleGuard®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For increased rate of weight gain and improved feed efficiency.

8.2 to 24.6 g/ton to provide 70 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the last 28 to 42 days on feed.

For improved feed efficiency and for the prevention and control of coccidiosis due to Eimeria bovis and E. zuernii.

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the last 28 to 42 days on feed.

For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the last 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency, and increased carcass leanness.

9.8 to 24.6 g/ton to provide 90 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the last 28 to 42 days on feed.

For increased rate of weight gain and improved feed efficiency.

Not to exceed 800 g/ton feeding a minimum of 1.0 lb/head/day to provide 70 to 400 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously for the last 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency, and increased carcass leanness.

9.8 to 24.6 g/ton to provide 90 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).

0.125 to 1.0 mg/lb fed at the rate of 0.5 to 2.0 lb/head/day (specify one level) to provide 0.25 to 0.5 mg/head/day (specify one level) of melengestrol acetate (as MGA®). Feed continuously as sole ration for the final 28 to 42 days on feed. 

For improved feed efficiency and for the prevention and control of coccidiosis due to Eimeria bovis and E.zuernii.

10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes.

8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.

For reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of Bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes); and reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. Only the sulfamethazine portion of this combination is active in controlling jowl abscesses.

Tylosin phosphate (100 g/ton) plus sulfamethazine (100 g/ton).

Withdraw 15 days before swine are slaughtered.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

0.25 to 2 g/ton (0.0000276 to 0.00022%) of MGA®, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylan™. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.

Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.

0.25 to 2 g/ton (0.0000276 to 0.00022%) of MGA®, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.

For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.

Melengestrol acetate, 0.25 to 0.50 milligram per head per day, plus lasalocid (as lasalocid sodium), 100 to 360 milligrams per head per day, and tylosin (as tylosin phosphate), 90 milligrams per head per day. To attain this amount:Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound to a medicated feed containing 10 to 30 grams of lasalocid and 8 to 10 grams of tylosin per ton; or Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound plus 50 to 720 milligrams of lasalocid per pound to 8 to 10 grams of tylosin per ton.

For heifers being fed in confinement for slaughter. 
Not effective in steers and spayed heifers.

This combination may only be marketed as a pelleted product.

Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.